CryoLife Inc. | Ownership

Companies that own CryoLife Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
4,817,746
13.1%
602,294
0.01%
06/30/2018
Capital Research & Management Co. (Global Investors)
3,055,251
8.31%
0
0.02%
06/30/2018
Dimensional Fund Advisors LP
2,002,485
5.45%
-5,411
0.02%
06/30/2018
The Vanguard Group, Inc.
1,887,138
5.13%
78,981
0%
06/30/2018
Macquarie Investment Management Business Trust
1,721,600
4.68%
-183,833
0.11%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
1,654,623
4.5%
-69,226
0.03%
06/30/2018
Northern Trust Investments, Inc.
1,210,790
3.29%
39,885
0.01%
06/30/2018
SSgA Funds Management, Inc.
947,010
2.58%
106,774
0%
06/30/2018
ArrowMark Colorado Holdings LLC
614,939
1.67%
-191,428
0.19%
06/30/2018
Renaissance Technologies LLC
573,990
1.56%
-64,810
0.02%
06/30/2018

About CryoLife

View Profile
Address
1655 Roberts Boulevard NW
Kennesaw Georgia 30144
United States
Employees -
Website http://www.cryolife.com
Updated 07/08/2019
CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes BioGlue; BioFoam; On-X products; CardioGenesis cardiac laser therapy; PerClot; PhotoFix, Hemodialysis Reliable Outflow Graft; and ProCol Vascular Bioprosthesis.